L2B project research
Public project information presented from the Leads 2 Business construction intelligence platform.
Project overview
Expansion and upgrade of the manufacturing facility in Roodepoort, Gauteng for Be-Tabs Pharmaceuticals, which is a division of Ranbaxy South Africa. The project will entail improving and upgrading an existing plant. Value: R100 million.
Ranbaxy South Africa is located in Gauteng. The project is classified in the Private sector. Its current recorded stage is Complete. The recorded project value is R 61 Million - R 200 Million.
Key information
Common questions
Ranbaxy South Africa is recorded as being located in Gauteng.
The current recorded project stage is Complete. Project information may change as new research becomes available.
Subscriber information may include professional team, awards and appointments, bidder information and project monitoring tools.
Continue exploring
Other projects relevant to Gauteng.
Gauteng
Stage: Procedural
Published 4 September 2023
Gauteng
Stage: Awarded
Published 30 January 2023
Gauteng
Stage: Design
Published 23 January 2023
Gauteng
Stage: L2B Shelved
Published 20 January 2023
Gauteng
Stage: Complete
Published 19 January 2023
Gauteng
Stage: L2B Shelved
Published 19 January 2023
Find your next opportunity
Leads 2 Business helps contractors, suppliers and professionals identify relevant opportunities and the people behind them.
Africa's leading construction, engineering and procurement companies.